Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
Detection of lung adenocarcinoma with ROS1 rearrangement by IHC, FISH, and RT-PCR and analysis of its clinicopathologic features. [electronic resource] by
- Cao, Bing
- Wei, Ping
- Liu, Zebing
- Bi, Rui
- Lu, Yongming
- Zhang, Ling
- Zhang, Jing
- Yang, Yusi
- Shen, Chen
- Du, Xiang
- Zhou, Xiaoyan
Producer: 20160115
In:
OncoTargets and therapy vol. 9
Availability: No items available.
|
|
12.
|
MYBL2 is an independent prognostic marker that has tumor-promoting functions in colorectal cancer. [electronic resource] by
- Ren, Fei
- Wang, Lisha
- Shen, Xiaohan
- Xiao, Xiuying
- Liu, Zebing
- Wei, Ping
- Wang, Yiqin
- Qi, Peng
- Shen, Chen
- Sheng, Weiqi
- Du, Xiang
Producer: 20150623
In:
American journal of cancer research vol. 5
Availability: No items available.
|
|
13.
|
Stomatin-like Protein 2 Promotes Tumor Cell Survival by Activating the JAK2-STAT3-PIM1 Pathway, Suggesting a Novel Therapy in CRC. [electronic resource] by
- Liu, Qiang
- Li, Anqi
- Wang, Lisha
- He, Wei
- Zhao, Ling
- Wu, Chao
- Lu, Shasha
- Ye, Xuanguang
- Zhao, Huiyong
- Shen, Xiaohan
- Xiao, Xiuying
- Liu, Zebing
Publication details: Molecular therapy oncolytics Jun 2020
In:
Molecular therapy oncolytics vol. 17
Availability: No items available.
|
|
14.
|
A molecular signature for the prediction of recurrence in colorectal cancer. [electronic resource] by
- Wang, Lisha
- Shen, Xiaohan
- Wang, Zhimin
- Xiao, Xiuying
- Wei, Ping
- Wang, Qifeng
- Ren, Fei
- Wang, Yiqin
- Liu, Zebing
- Sheng, Weiqi
- Huang, Wei
- Zhou, Xiaoyan
- Du, Xiang
Producer: 20160111
In:
Molecular cancer vol. 14
Availability: No items available.
|
|
15.
|
BATF2 Deficiency Promotes Progression in Human Colorectal Cancer via Activation of HGF/MET Signaling: A Potential Rationale for Combining MET Inhibitors with IFNs. [electronic resource] by
- Liu, Zebing
- Wei, Ping
- Yang, Yu
- Cui, Wenli
- Cao, Bing
- Tan, Cong
- Yu, Baohua
- Bi, Rui
- Xia, Kaiqin
- Chen, Weixiang
- Wang, Yiqin
- Zhang, Youyuan
- Du, Xiang
- Zhou, Xiaoyan
Producer: 20160301
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 21
Availability: No items available.
|
|
16.
|
Activation of MET signaling by HDAC6 offers a rationale for a novel ricolinostat and crizotinib combinatorial therapeutic strategy in diffuse large B-cell lymphoma. [electronic resource] by
- Liu, Zebing
- Cai, Ying
- Yang, Yu
- Li, Anqi
- Bi, Rui
- Wang, Lisha
- Shen, Xiaohan
- Wang, Weige
- Jia, Yijun
- Yu, Baohua
- Cao, Bing
- Cui, Wenli
- Wei, Ping
- Zhou, Xiaoyan
Producer: 20191022
In:
The Journal of pathology vol. 246
Availability: No items available.
|